Pressure BioSciences Awarded $649,000 Grant From the Department of Defense ("DoD")
October 13, 2011 13:16 ET
|
Pressure BioSciences, Inc.
Non-Dilutive Funding for the Development of an Automated, High-Throughput, PCT Based System to Help in the Detection of Highly Pathogenic Organisms
Total of $809,000 of Non-Dilutive...
Leading, Independent Researchers Report Significant Advantages of Pressure Cycling Technology (PCT) at Multiple Scientific Conferences
October 11, 2011 10:13 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Oct. 11, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company") today announced that leading, independent researchers from academia,...
Pressure BioSciences, Inc. Awarded NIH SBIR Phase I Grant for the Development of an Automated, Pressure-Enhanced System for the Routine Processing of Cancer and Other Tissue Samples
September 06, 2011 09:27 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Sept. 6, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company") today announced that it has been awarded a $160,978 SBIR Phase I grant...
Pressure BioSciences, Inc. Reiterates Optimistic Outlook for 2H 2011
August 31, 2011 10:40 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today reiterated its optimistic revenue and operational outlook for the third...
Pressure BioSciences, Inc. to Discuss Second Quarter 2011 Financial Results and Provide Business Update
August 16, 2011 16:41 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) today announced that the Company will host a teleconference to discuss its Q2 2011 financial results and...
Jeffrey N. Peterson Joins Pressure BioSciences, Inc. Board; Release of Second Tranche Brings Private Placement Receipts to Over $1.1 M
June 22, 2011 10:01 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., June 22, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that Mr. Jeffrey N. Peterson, CEO of Target Discovery, Inc....
Pressure BioSciences, Inc. Granted Extension to October 3, 2011 to Regain Compliance With NASDAQ Minimum Stockholders' Equity Requirement
June 15, 2011 09:23 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., June 15, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that the Company received a notice from NASDAQ on June 10, 2011...
Pressure BioSciences, Inc. Reports Financial Results for the First Quarter of 2011 and Provides Business Update
May 17, 2011 09:29 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., May 17, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced financial results for the first quarter of 2011.
Revenue from...
Pressure BioSciences, Inc. and KeraFAST LLC Sign Worldwide E-Commerce Distribution Deal
May 03, 2011 08:45 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., May 3, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company") and KeraFAST LLC ("KeraFAST") today announced that they have entered into a...
Pressure BioSciences, Inc. Receives $825,720 as the First Tranche of a $6.0 Million Private Placement
April 13, 2011 09:18 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., April 13, 2011 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" or the "Company") today announced that it has received gross proceeds of $825,720 from the sale...